NEW BRUNSWICK, N.J. — Johnson & Johnson (J&J) took another step forward on Thursday in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned new consumer health company. According to the company, “Kenvue (pronounced ken·view), is inspired by two powerful ideas: “ken” – meaning knowledge, an English word
NEW BRUNSWICK, N.J. — Johnson & Johnson announced Monday the appointment of Larry Merlo as non-executive chair designate for the future, listed New Consumer Health Company’s Board of Directors. Merlo previously served as president and CEO of CVS Health and brings over 30 years of purpose-driven and transformative health leadership to the Board for the
NEW YORK — Johnson & Johnson announced that the company will no longer sell its talcum-based baby powder worldwide and replace the product with its existing cornstarch version starting next year, the consumer products giant said last week. This move comes after thousands of lawsuits from women in recent years who claimed using the powder
NEW YORK — Johnson & Johnson announced on Friday plans to split into two companies, separating its consumer health division from its pharmaceuticals and medical devices business. This has been the case in the health care arena where the slow-and-steady business of selling consumer products such as moisturisers and shampoos has increasingly diverged from the
WASHINGTON — A panel of U.S. health advisers endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine Friday, saying they should be offered at least two months after immunization. J&J has requested the Food and Drug Administration for flexibility with its booster, arguing the extra dose adds important protection as early as two months after
NEW BRUNSWICK, N.J. — Johnson & Johnson announced that Dr. Paul Stoffels, currently vice chairman of the executive committee and chief scientific officer of Johnson & Johnson, will retire from the company effective December 31, 2021. As the vice chairman of the executive committee and chief scientific officer, Dr. Stoffels spearheaded the company’s research and
NEW YORK — Johnson & Johnson announced on Tuesday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its Covid-19 vaccine in people ages 18 years and older. While scientists are divided over the need for booster shots when so many people in the
NEW YORK — Johnson & Johnson said on Tuesday that its one-shot COVID-19 vaccine has performed well in real-world studies, offers long-lasting protection against the virus and boosts the immune system when administered as a booster a few months after the original dose. The company made the announcement in a release of late-stage clinical data
NEW YORK – Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies announced this weekend a settlement agreement with the State of New York and its participating subdivisions, including Nassau County and Suffolk County, resolving their opioid-related claims against the company. With this agreement, the company is removed from the trial scheduled to begin in
WASHINGTON — According to published reports, the U.S. Food and Drug Administration (FDA) has found the single-shot Johnson & Johnson coronavirus vaccine to be safe and effective. This move paves the way for it to become the third COVID-19 vaccine to be authorised in the US, possibly by tomorrow. The vaccine would be a cost-effective
NEW BRUNSWICK, N.J. – Johnson & Johnson announced that it has entered into a definitive agreement to acquire Momenta Pharmaceuticals (Momenta), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. The deal provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson
NEW YORK — Johnson & Johnson‘s Band-Aid has announced it will be introducing a new range of bandages “that embrace the beauty of diverse skin.” In an Instagram post, the brand revealed that it will be launching the products in light, medium and deep shades of Brown and Black skin tones. “We stand in solidarity
NEW BRUNSWICK, N.J. — As part of a portfolio assessment related to COVID-19, in March, Johnson & Johnson Consumer Health announced on Tuesday that it has stopped shipping hundreds of items in the U.S. and Canada to prioritize high-demand products and to allow for appropriate social distancing in manufacturing and distribution facilities during this unprecedented
NEW BRUNSWICK, N.J. – Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA); and the rapid scaling of
